4-bromo-a-23187 has been researched along with atrial natriuretic factor in 1 studies
| Studies (4-bromo-a-23187) | Trials (4-bromo-a-23187) | Recent Studies (post-2010) (4-bromo-a-23187) | Studies (atrial natriuretic factor) | Trials (atrial natriuretic factor) | Recent Studies (post-2010) (atrial natriuretic factor) |
|---|---|---|---|---|---|
| 63 | 0 | 5 | 15,455 | 1,105 | 1,760 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiemer, AK; Vollmar, AM | 1 |
1 other study(ies) available for 4-bromo-a-23187 and atrial natriuretic factor
| Article | Year |
|---|---|
Elevation of intracellular calcium levels contributes to the inhibition of nitric oxide production by atrial natriuretic peptide.
Topics: Aniline Compounds; Animals; Atrial Natriuretic Factor; Calcimycin; Calcium; Cells, Cultured; Dibutyryl Cyclic GMP; Fluorescent Dyes; Guanylate Cyclase; Lipopolysaccharides; Macrophages; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Polysaccharides; Receptors, Atrial Natriuretic Factor; Thapsigargin; Xanthenes | 2001 |